These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12688200)

  • 21. [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):4-5. PubMed ID: 15219114
    [No Abstract]   [Full Text] [Related]  

  • 22. A prospective study of pravastatin in the elderly at risk: new hope for older persons.
    Shepherd J
    Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):17-24. PubMed ID: 15133425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?].
    Pöss J; Böhm M; Laufs U
    Med Klin (Munich); 2009 Jan; 104(1):74-8. PubMed ID: 19142597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

  • 25. Statins: much more than just a lipid-lowering therapy.
    Raja SG; Dreyfus GD
    Indian Heart J; 2004; 56(3):204-9. PubMed ID: 15584561
    [No Abstract]   [Full Text] [Related]  

  • 26. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Despite coronary intervention, the risk remains high: PCI patients need additional protection].
    MMW Fortschr Med; 2004 Jun; 146(24):3. PubMed ID: 15366508
    [No Abstract]   [Full Text] [Related]  

  • 30. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy.
    Wiviott SD; Cannon CP; Morrow DA; Ray KK; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1411-6. PubMed ID: 16226163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis.
    Ebrahimi R; Saleh J; Toggart E; Shah AP; Azmoon S; Babaei H; Lee J; Smith R; Movahed MR; Rubin SA
    J Invasive Cardiol; 2008 Jun; 20(6):292-5. PubMed ID: 18523323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pravastatin therapy and the risk of stroke.
    Fruchter O
    N Engl J Med; 2000 Dec; 343(25):1895; author reply 1895-6. PubMed ID: 11117990
    [No Abstract]   [Full Text] [Related]  

  • 34. Statin face-off. Surprises from the first head-to-head comparison.
    Gupta S
    Time; 2003 Nov; 162(21):83. PubMed ID: 14666603
    [No Abstract]   [Full Text] [Related]  

  • 35. More on PROSPER.
    Wierzbicki AS; Mikhailidis DP; Reynolds TM
    Lancet; 2003 Mar; 361(9363):1135-6; author reply 1136. PubMed ID: 12672344
    [No Abstract]   [Full Text] [Related]  

  • 36. Pravastatin therapy and the risk of stroke.
    Meilof JF; Uitdehaag BM
    N Engl J Med; 2000 Dec; 343(25):1895; author reply 1895-6. PubMed ID: 11117989
    [No Abstract]   [Full Text] [Related]  

  • 37. Statins & Alzheimer's.
    Feinberg AW
    Health News; 2000 Dec; 6(12):1. PubMed ID: 11142934
    [No Abstract]   [Full Text] [Related]  

  • 38. [Statins and cardiovascular disease prevention: use and prospective].
    Moulin P
    Nephrologie; 2000; 21(7):379-80. PubMed ID: 11200617
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
    Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
    Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
    Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
    Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.